Cover Image
市場調查報告書

尿道導管的全球市場:醫療設備的開發平台評估

Urinary Catheters - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 358894
出版日期 內容資訊 英文 167 Pages
訂單完成後即時交付
價格
Back to Top
尿道導管的全球市場:醫療設備的開發平台評估 Urinary Catheters - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年07月01日 內容資訊: 英文 167 Pages
簡介

本報告提供全球尿道導管市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的進展各階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 尿道導管概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各部門
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 臨床實驗中的開發中產品:各企業

  • 尿道導管的企業:各臨床實驗階段的開發中產品
  • 尿道導管:各臨床實驗階段的開發中產品

第5章 尿道導管市場:企業·產品概要

  • Applied Catheter Technologies Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Ceragenix Pharmaceuticals, Inc. (Inactive)
  • Enox Biopharma, Inc
  • FocusStart LLC
  • Marvao Medical Devices Limited
  • Olympus Corporation Medical Systems
  • Sharklet Technologies, Inc.
  • Teleflex Incorporated
  • The University of Utah
  • University of California, San Diego
  • University of Nottingham
  • Urovalve, Inc.
  • Xennovate Medical LLC

第6章 尿道導管市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0374EPD

GlobalData's Medical Devices sector report, "Urinary Catheters - Medical Devices Pipeline Assessment, 2017" provides an overview of Urinary Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urinary Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Urinary Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Urinary Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Urinary Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Urinary Catheters Overview 8

3 Products under Development 9

  • 3.1 Urinary Catheters - Pipeline Products by Stage of Development 9
  • 3.2 Urinary Catheters - Pipeline Products by Segment 10
  • 3.3 Urinary Catheters - Pipeline Products by Territory 11
  • 3.4 Urinary Catheters - Pipeline Products by Regulatory Path 12
  • 3.5 Urinary Catheters - Pipeline Products by Estimated Approval Date 13

4 Urinary Catheters - Pipeline Products under Development by Companies 14

  • 4.1 Urinary Catheters Companies - Pipeline Products by Stage of Development 14
  • 4.2 Urinary Catheters - Pipeline Products by Stage of Development 15

5 Urinary Catheters Companies and Product Overview 16

  • 5.1 Applied Catheter Technologies Inc. Company Overview 16
    • 5.1.1 Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Biocrede Inc Company Overview 17
    • 5.2.1 Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 BioModics ApS Company Overview 18
    • 5.3.1 BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.4 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 19
    • 5.4.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.5 Coloplast A/S Company Overview 20
    • 5.5.1 Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 Control Flo Medical LLC Company Overview 22
    • 5.6.1 Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.7 ConvaTec Inc. Company Overview 23
    • 5.7.1 ConvaTec Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.8 Enox Biopharma Inc Company Overview 24
    • 5.8.1 Enox Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.9 FocusStart LLC Company Overview 25
    • 5.9.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.10 Hollister Incorporated Company Overview 26
    • 5.10.1 Hollister Incorporated Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.11 Marvao Medical Devices Limited Company Overview 29
    • 5.11.1 Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.12 Olympus Medical Systems Corp Company Overview 30
    • 5.12.1 Olympus Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.13 Sharklet Technologies, Inc. Company Overview 31
    • 5.13.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.14 The University of Utah Company Overview 32
    • 5.14.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.15 University of California San Diego Company Overview 33
    • 5.15.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.16 University of Nottingham Company Overview 34
    • 5.16.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.17 Urovalve, Inc. Company Overview 35
    • 5.17.1 Urovalve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.18 Xennovate Medical LLC Company Overview 37
    • 5.18.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 37

6 Urinary Catheters- Recent Developments 39

  • 6.1 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact 39
  • 6.2 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 40
  • 6.3 Jun 26, 2017: Henry Ford Welcomes Three New Senior Executives 42
  • 6.4 Jun 21, 2017: ConvaTec Group: Board appointment 43
  • 6.5 Jun 09, 2017: Poly Medicure announces appointment of Chief Operating Officer 43
  • 6.6 May 29, 2017: Covalon Releases Second Quarter Financial Results 44
  • 6.7 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 44
  • 6.8 May 17, 2017: Kane Biotech - Q1 2017 Financial Reports 47
  • 6.9 May 15, 2017: Henry Ford Health System Welcomes New Lansing Based Government Affairs Manager 48
  • 6.10 May 15, 2017: Henry Ford Wyandotte Hospital Welcomes Two Top Leaders 48
  • 6.11 May 15, 2017: INVO Bioscience Reports First Quarter 2017 Financial Results 49
  • 6.12 May 10, 2017: Newly Published Data Affirms Ability of Spanner Temporary Prostate Stent to Replace Urinary Catheters in Men 50
  • 6.13 May 08, 2017: B. Braun To Introduce Actreen Mini Catheters at AUA 51
  • 6.14 May 04, 2017: ConvaTec Group: Trading Update for the three months ended 31 March 2017 51
  • 6.15 May 04, 2017: Bactiguard: Interim report for Q1 2017 53
  • 6.16 May 04, 2017: Teleflex Reports First Quarter 2017 Results 54
  • 6.17 May 03, 2017: Coloplast delivers satisfactory Q2 result 56
  • 6.18 May 03, 2017: Covalon to Exhibit at the 2017 European Wound Management Association's Annual Conference 57
  • 6.19 May 03, 2017: Bactiguard appoints new distributor in Brazil 57
  • 6.20 May 02, 2017: Medline Names New President of Canadian Business 58
  • 6.21 Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results 58
  • 6.22 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 65
  • 6.23 Apr 23, 2017: Bard Announces First Quarter Results 66
  • 6.24 Apr 21, 2017: Henry Ford Cancer Institute Appoints Vice President, Executive Director 67
  • 6.25 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia 67
  • 6.26 Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication 68
  • 6.27 Apr 11, 2017: INVO Bioscience Appoints Renowned Fertility Specialist Dr. Kevin Doody to its Board of Directors 69
  • 6.28 Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee 70
  • 6.29 Apr 03, 2017: Generous Foundation Grant to Help Start New Global Technology Development Program at Henry Ford Health System 70
  • 6.30 Mar 29, 2017: ConvaTec Group: Directorate changes 71
  • 6.31 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute 72
  • 6.32 Mar 28, 2017: ConvaTec: Proposed Directorate Changes 73
  • 6.33 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair 73
  • 6.34 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 74
  • 6.35 Mar 08, 2017: CooperGenomics Receives ISO 15189 Accreditation in United Kingdom Laboratories for Noninvasive Prenatal Testing 74
  • 6.36 Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results 75
  • 6.37 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 77
  • 6.38 Mar 06, 2017: Medline Announces New Chief Marketing Officer 78
  • 6.39 Mar 02, 2017: Sanofi's Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors 79
  • 6.40 Feb 24, 2017: Dynarex Announces New Executive Appointments 79
  • 6.41 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 80
  • 6.42 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 80
  • 6.43 Feb 22, 2017: ConvaTec Launches GentleCath Glide And me+ Direct-to-Consumer Programme For Intermittent Catheter Users 82
  • 6.44 Feb 21, 2017: New clinical study from Hong Kong confirms that Bactiguard coated Foley catheters reduce infections for long-term users 83
  • 6.45 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 83
  • 6.46 Feb 17, 2017: Dentsply Sirona Reports Fourth Quarter and Full Year 2016 Results 86
  • 6.47 Feb 09, 2017: Year-end Report 2016 Bactiguard Holding 88
  • 6.48 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER 90
  • 6.49 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department 99
  • 6.50 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 100
  • 6.51 Feb 02, 2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance 100
  • 6.52 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 101
  • 6.53 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 102
  • 6.54 Feb 01, 2017: Bactiguard expands in the Middle East 103
  • 6.55 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs 104
  • 6.56 Jan 30, 2017: Covalon Posts Record First Quarter Financial Results 104
  • 6.57 Jan 26, 2017: Degania Silicone Enters into an Agreement with Control Flo Medical for the Design & Manufacturing of the Patented ResQ Urological Catheter System 105
  • 6.58 Jan 26, 2017: Henry Ford Cancer Institute Earns Distinct Level of Accreditation 105
  • 6.59 Jan 26, 2017: Bard Announces Fourth Quarter Results 107
  • 6.60 Jan 04, 2017: Henry Ford Health System Welcomes New President and CEO 107
  • 6.61 Jan 03, 2017: Covalon CEO Provides Update on Anticipated Fiscal 2017 Financial Growth 108
  • 6.62 Dec 30, 2016: Medline Makes it Easier for Patients to Receive Critical Supplies through New Patient Home Direct Deal with ViaQuest 110
  • 6.63 Dec 15, 2016: Bactiguard Enters Germany 111
  • 6.64 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 111
  • 6.65 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 114
  • 6.66 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 115
  • 6.67 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 115
  • 6.68 Nov 10, 2016: Bactiguard Holding: Interim report for Q3 2016 116
  • 6.69 Nov 07, 2016: Bactiguard: New Major Order from China 118
  • 6.70 Nov 07, 2016: Bactiguard Holding: New Major Order from China 118
  • 6.71 Nov 04, 2016: Dentsply Sirona Reports Third Quarter 2016 Results 118
  • 6.72 Nov 02, 2016: Coloplast delivers full-year results in line with guidance 119
  • 6.73 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results 120
  • 6.74 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 127
  • 6.75 Oct 26, 2016: New clinical study confirms that Bactiguard coated Foley catheters reduce infections in ICU 130
  • 6.76 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 130
  • 6.77 Oct 25, 2016: Bard Announces Third Quarter Results 132
  • 6.78 Oct 17, 2016: Bactiguard continues cooperation with the Swedish counties Kronoberg and Blekinge 132
  • 6.79 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs 132
  • 6.80 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 133
  • 6.81 Oct 06, 2016: User-Friendly Urinary Catheter Gets FDA Clearance 134
  • 6.82 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 134
  • 6.83 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare 135
  • 6.84 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 135
  • 6.85 Sep 14, 2016: New flexible catheter part of Coloplast growth plan 136
  • 6.86 Sep 13, 2016: New clinical study at the Martini-Klinik to improve care for prostate cancer patients 137
  • 6.87 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation 137
  • 6.88 Sep 06, 2016: Sanofi Board Of Directors Provides Update 138
  • 6.89 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 138
  • 6.90 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 139
  • 6.91 Aug 19, 2016: Covalon Announces Third Quarter Financial Results 141
  • 6.92 Aug 16, 2016: Coloplast delivers 9M result in line with guidance 142
  • 6.93 Aug 11, 2016: Interim report for Bactiguard Holding 143
  • 6.94 Aug 10, 2016: New Major Order From India Announced By Bactiguard 146
  • 6.95 Aug 05, 2016: Dentsply Sirona Reports Second Quarter 2016 Results 147
  • 6.96 Jul 29, 2016: Sanofi Announces Q2 2016 Results 148
  • 6.97 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi 156
  • 6.98 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 157
  • 6.99 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 158
  • 6.100 Jul 26, 2016: Bard Announces Second Quarter Results 160
  • 6.101 Jul 20, 2016: Mike Stone Appointed as Managing Director, Dentsply Sirona Australia and New Zealand 160
  • 6.102 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 161
  • 6.103 Jul 12, 2016: McShane Construction Company Marks Significant Progress at New 630,000 S.F. Medical Supplies Distribution Center in Phoenix, Arizona 161
  • 6.104 Jul 06, 2016: Putting Company Culture First Spurs Growth and the Formation of Alliant Surgical Products in Grand Rapids, MI 162
  • 6.105 Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information 163

7 Appendix 164

  • 7.1 Methodology 164
  • 7.2 About GlobalData 167
  • 7.3 Contact Us 167
  • 7.4 Disclaimer 167

List of Tables

1.1 List of Tables

  • Table 1: Urinary Catheters - Pipeline Products by Stage of Development 9
  • Table 2: Urinary Catheters - Pipeline Products by Segment 10
  • Table 3: Urinary Catheters - Pipeline Products by Territory 11
  • Table 4: Urinary Catheters - Pipeline Products by Regulatory Path 12
  • Table 5: Urinary Catheters - Pipeline Products by Estimated Approval Date 13
  • Table 6: Urinary Catheters Companies - Pipeline Products by Stage of Development 14
  • Table 7: Urinary Catheters - Pipeline Products by Stage of Development 15
  • Table 8: Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 9: Drug Coated Catheter - Product Status 16
  • Table 10: Drug Coated Catheter - Product Description 16
  • Table 11: Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 12: Urinary Catheter - Product Status 17
  • Table 13: Urinary Catheter - Product Description 17
  • Table 14: BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 15: Indwelling Urinary Catheter - Product Status 18
  • Table 16: Indwelling Urinary Catheter - Product Description 18
  • Table 17: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 18: Cerashield Coated Silicone Urinary Catheter - Product Status 19
  • Table 19: Cerashield Coated Silicone Urinary Catheter - Product Description 19
  • Table 20: Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 21: SpeediCath Compact Eve CH10 - Product Status 20
  • Table 22: SpeediCath Compact Eve CH10 - Product Description 20
  • Table 23: SpeediCath Compact Eve CH14 - Product Status 21
  • Table 24: SpeediCath Compact Eve CH14 - Product Description 21
  • Table 25: Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 26: ResQ Urological Catheter System - Product Status 22
  • Table 27: ResQ Urological Catheter System - Product Description 22
  • Table 28: ConvaTec Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 29: GentleCath Glide Intermittent Catheter - Product Status 23
  • Table 30: GentleCath Glide Intermittent Catheter - Product Description 23
  • Table 31: Enox Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 32: Self-Sterilizing Urinary Catheter - Product Status 24
  • Table 33: Self-Sterilizing Urinary Catheter - Product Description 24
  • Table 34: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 35: Anti-biofilm Urological Catheter - Product Status 25
  • Table 36: Anti-biofilm Urological Catheter - Product Description 25
  • Table 37: Hollister Incorporated Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 38: VaPro Touch Free Female Hydrophilic Intermittent Catheter - Product Status 26
  • Table 39: VaPro Touch Free Female Hydrophilic Intermittent Catheter - Product Description 27
  • Table 40: VaPro Touch Free Male Hydrophilic Intermittent Catheter - Product Status 27
  • Table 41: VaPro Touch Free Male Hydrophilic Intermittent Catheter - Product Description 28
  • Table 42: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 43: NexSite Drainage Catheter - Product Status 29
  • Table 44: NexSite Drainage Catheter - Product Description 29
  • Table 45: Olympus Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 46: Uro-Ease - Product Status 30
  • Table 47: Uro-Ease - Product Description 30
  • Table 48: Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 49: Foley Urinary Catheter - Product Status 31
  • Table 50: Foley Urinary Catheter - Product Description 31
  • Table 51: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 52: AdvanceCath Catheter - Product Status 32
  • Table 53: AdvanceCath Catheter - Product Description 32
  • Table 54: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 55: Urethral Catheter - Product Status 33
  • Table 56: Urethral Catheter - Product Description 33
  • Table 57: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 58: Antimicrobial Catheter - Product Status 34
  • Table 59: Antimicrobial Catheter - Product Description 34
  • Table 60: Urovalve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 61: FolEase Catheter - Product Status 35
  • Table 62: FolEase Catheter - Product Description 35
  • Table 63: Surinate Bladder Management System - Product Status 36
  • Table 64: Surinate Bladder Management System - Product Description 36
  • Table 65: Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 66: ProSeal Ultra Condom Catheter - Product Status 37
  • Table 67: ProSeal Ultra Condom Catheter - Product Description 37
  • Table 68: Vortex ZDS Urinary Retention Catheter - Product Status 38
  • Table 69: Vortex ZDS Urinary Retention Catheter - Product Description 38
  • Table 70: Glossary 166

List of Figures

1.2 List of Figures

  • Figure 1: Urinary Catheters - Pipeline Products by Stage of Development 9
  • Figure 2: Urinary Catheters - Pipeline Products by Segment 10
  • Figure 3: Urinary Catheters - Pipeline Products by Territory 11
  • Figure 4: Urinary Catheters - Pipeline Products by Regulatory Path 12
  • Figure 5: Urinary Catheters - Pipeline Products by Estimated Approval Date 13
Back to Top